Sivik Global Healthcare LLC Blueprint Medicines Corp Transaction History

Sivik Global Healthcare LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$54.1 - $110.08 $541,000 - $1.1 Million	-10,000 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$94.25 - $115.99 $942,500 - $1.16 Million	10,000 New	10,000 $1.07 Million
Q1 2020 May 15, 2020	SELL	$48.11 - $82.22 $890,997 - $1.52 Million	-18,520 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$66.73 - $82.59 $98,760 - $122,233	-1,480 Reduced 7.4%	18,520 $1.48 Million
Q3 2019 Nov 12, 2019	SELL	$72.9 - $101.41 $729,000 - $1.01 Million	-10,000 Reduced 33.33%	20,000 $1.47 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $367,700 - $489,000	5,000 Added 20.0%	30,000 $2.83 Million
Q1 2019 May 08, 2019	BUY	$48.7 - $86.6 $1.22 Million - $2.17 Million	25,000 New	25,000 $2 Million
Q4 2018 Feb 12, 2019	SELL	$45.57 - $74.26 $1.59 Million - $2.6 Million	-35,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$58.91 - $78.32 $2.06 Million - $2.74 Million	35,000 New	35,000 $2.73 Million
Q2 2018 Aug 06, 2018	SELL	$60.96 - $101.18 $1.22 Million - $2.02 Million	-20,000 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$62.91 - $88.32 $1.26 Million - $1.77 Million	20,000	20,000 $1.51 Million

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.